Artelo Biosciences Receives $3.0 Million in Net Proceeds from Exercise of Warrants
LA JOLLA, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing...
News
Entera Bio Initiates New Research Program For Oral GLP-2
‒ Program Leverages Entera’s Platform for Potential Development of Oral GLP-2 Analogs for Gastrointestinal and Other Indications ‒‒ GLP-2 Analogs...
AzurRx BioPharma to Present at BIO CEO & Investor Digital Conference
DELRAY BEACH, Fla., Feb. 08, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company...
Algernon Pharmaceuticals Signs Agreement with Charles River Laboratories for DMT Preclinical Studies
VANCOUVER, British Columbia, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
Cue Biopharma Initiates Patient Dosing in Phase 1 Study of CUE-101 in Combination with KEYTRUDA® (pembrolizumab) as First-line Treatment for HPV+ Recurrent/Metastatic Head and Neck Cancer
CAMBRIDGE, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel...
Editas Medicine Announces Appointment of James C. Mullen as Chief Executive Officer
Cindy Collins to Step Down Effective February 15, 2021 James C. Mullen Editas Medicine announces the appointment of James C....
Learning to Prevent the Next Pandemic: VaxHunt Game Earns STEM.org Educational Trustmark
The Influenzer Initiative’s online game earns the STEM.org Authenticated™ Educational Product Trustmark VaxHunt: The Quest to Prevent the Next Pandemic...
Sigilon Therapeutics Announces Preclinical Data in Multiple Lysosomal Diseases at the 17th Annual WORLDSymposium™
Results demonstrate potential of Company’s therapies developed using its novel Shielded Living Therapeutics™ platform to treat broad range of chronic diseasesCAMBRIDGE,...
Clubhouse Media Group Closes Acquisition of Magiclytics
LOS ANGELES, Feb. 08, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clubhouse Media Group, Inc. (OTCMKTS: CMGR) (“Clubhouse Media” or...
Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines
WALTHAM, Mass. and HALLE (Saale), Germany, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused...
AIDS Healthcare Foundation Selects the Inovalon ONE® Platform
World’s Largest Provider of HIV/AIDS Medical Care Will Implement ScriptMed® Cloud to Improve Clinical Outcomes for PatientsBOWIE, Md., Feb. 08,...
Paratek Announces Expansion of NUZYRA® Launch into the Community Setting
Building on the successful hospital-focused launch of NUZYRA, Paratek is expanding commercial promotion of NUZYRA into the community setting aimed...
VitalHub Announces Licensing Deal with Surrey and Sussex Healthcare NHS Trust
TORONTO, Feb. 08, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce a...
Dyne Therapeutics Appoints Ashish Dugar, Ph.D., MBA, Senior Vice President, Global Head of Medical Affairs
Dr. Dugar Brings Over 20 Years of Experience in Medical Affairs, Clinical and Commercial Development, and Real-World Evidence, Including in...
Clearside Biomedical Featured in Multiple Data Presentations at the 44th Virtual Annual Macula Society Meeting
- Proprietary suprachoroidal injection platform demonstrates broad applicability across multiple retinal disorders - - CLS-AX will also be featured at...
MacroGenics to Participate in Upcoming Investor Conferences
ROCKVILLE, MD, Feb. 08, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and...
GeneSight Psychotropic Test’s Combinatorial Approach Proves Better than Single-Gene Testing at Predicting Patient Outcomes and Medication Blood Levels
New Analysis Published in Psychiatry Research SALT LAKE CITY, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a...
Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook on Thursday, February 11, 2021
Conference Call and Webcast To be Held Thursday, February 11, 2021 4:30 pm Eastern TimeNEW YORK, Feb. 08, 2021 (GLOBE...
IN8bio Appoints Patrick McCall as Chief Financial Officer
NEW YORK, Feb. 08, 2021 (GLOBE NEWSWIRE) -- IN8bio, Inc., a clinical-stage biotechnology company focused on developing innovative allogeneic, autologous...
Annexon Welcomes William H. Carson, M.D. to the Board of Directors
Thomas G. Wiggans appointed ChairmanSOUTH SAN FRANCISCO, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical...